The 20 Best Large-Cell Lung Carcinoma Doctors Near Me in Bronx, NY

Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Dr. Kalnicki focuses on researching and implementing new technologies in the radiation treatment of cancer, with the aim of enhancing the dose to the tumor target while preserving normal tissues from radiation injury, potentially increasing tumor control and improving quality of life. He pioneered the use of intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), target motion management with 4-D radiation planning, stereotactic body radiation therapy (SBRT) and functional tumor imaging with PET-CT (positron emission tomography – CAT scan) fusion techniques. His research has implications for radiation treatment planning and techniques used for most clinical situations in radiation oncology, including brain, head and neck, thoracic, upper abdominal and pelvic malignancies. Dr. Kalnicki is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Anal Cancer, Cervical Cancer, and Prostatectomy. Dr. Kalnicki is board certified in American Board Of Radiology, Inc..

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Haiying Cheng is an Oncologist practicing medicine in Bronx, New York. Dr. Cheng is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Dr. Rasim Gucalp’s research interests include novel therapies in lung cancer as well as supportive care in cancer patients. He is actively involved in the multidisciplinary care of patients with lung cancer and central nervous system tumors. He is a member of several Montefiore Medical Center/Albert Einstein College of Medicine committees including the institutional tumor board, faculty senate, Pharmacy and Therapeutic Committee, and COGME. Dr. Gucalp is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.

Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, and has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she runs the thoracic oncology clinical trial portfolio and devotes part of her research effort to patients with targetable mutations such as EGFR. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients. Dr. Shu is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Salpingo-Oophorectomy. Dr. Shu is board certified in Internal Medicine and Medical Oncology. Dr. Shu is currently accepting new patients.

Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract. As the Director of the HICCC Phase I Unit and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit side effects from, emerging cancer treatments. These efforts entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from immunotherapy. Dr. Henick is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Henick is board certified in Internal Medicine. Dr. Henick is currently accepting new patients.

William Bodner is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Bodner is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

My research is focused on breast cancer management, and on care delivery and support for breast cancer patients. Dr. Makower is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.

Byung-han Rhieu is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Rhieu is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Radiation Induced Meningioma, Meningioma, and Primitive Neuroectodermal Tumor (PNET).

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Chirag Shah is a Pulmonary Medicine provider practicing medicine in Bronx, New York. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His clinical expertise encompasses Lung Metastases, Lung Nodules, Bronchiectasis, and Pneumonia.

Clinical Specialty Areas. Dr. Dobkin is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, Lung Metastases, and Bronchiectasis.

Stuart Packer, MD, is a medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer. After graduating magna cum laude from Case Western Reserve University, Dr. Packer received his medical degree from the State University of New York/Downstate Medical Center. He went on to complete a residency in medicine and fellowship in hematology/medical oncology at Duke University Medical Center. Since then Dr. Packer has held clinical and teaching positions at leading cancer centers, including Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and Montefiore Einstein Center for Cancer Care. Dr. Packer is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Throat Cancer, and Laryngeal Cancer.

Avi Einzig is an Oncologist practicing medicine in Bronx, New York. Dr. Einzig is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Bahar Laderian, MD, is Director of the Neuroendocrine Tumors Program at Montefiore Einstein Comprehensive Cancer Center and Assistant Professor of Medicine and Oncology at Albert Einstein College of Medicine. Dr. Laderian’s clinical focus is on the treatment of neuroendocrine tumors (carcinoid), adrenocortical carcinoma and carcinomas, pheochromocytomas, paragangliomas, and gastrointestinal cancers including anal cancers, colorectal cancers, cancer of the appendix, intestinal cancers, anal cancers, pancreatic cancers, hepatocellular carcinomas, cholangiocarcinomas and gastroesophageal cancers. Dr. Laderian is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Glomus Tympanum Tumor, Glomus Jugulare Tumor, Lynch Syndrome, Gastroesophageal Junction Cancer, and Gamma Knife Radiosurgery.

Christopher Jakubowski, MD, is Associate Director, Genitourinary Oncology at Montefiore Einstein and Assistant Professor, Medical Oncology at our Albert Einstein College of Medicine. Dr. Jakubowski’s clinical focus centers on prostate cancer, bladder cancer, kidney cancer and testicular cancer. Dr. Jakubowski is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Lung Cancer, Cholangiocarcinoma (Bile Duct Cancer), Prostate Cancer, and Nephrectomy.

Noah Kornblum is an Oncologist practicing medicine in Bronx, New York. Dr. Kornblum is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Adult T-Cell Leukemia, Multiple Myeloma, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Nephrectomy, and Prostatectomy.

Jesus Anampa Mesias, MD is a medical oncologist at Montefiore Einstein Comprehensive Cancer Center and a member of its Cancer Therapeutics Research Program focused on identifying new treatment targets and novel cancer therapeutics. He is fluent in Spanish and enjoys participating in bilingual community activities about cancer prevention and treatment in our community. Dr. Mesias is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer.